You are here: Industry Insights > Zika

News List

Co-Diagnostics gets CE mark for Zika, Dengue, Chikungunya diagnostic test biospectrumasia
March 12, 2019
Co-Diagnostics, a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced that its Logix Smart™ ZDC Test has obtained CE mark regulatory clearance to be sold as an in vitro diagnostic (“I
Scientists weigh Zika challenge study: report fiercepharma
December 12, 2018
Zika captured the world's attention when microcephaly cases started popping up in Brazil back in 2015, and in a fast response, governments and industry quickly committed resources for vaccine research.
Emergent and Valneva's Zika vaccine clears phase 1 fiercepharma
December 11, 2018
A Zika vaccine candidate co-developed by Emergent BioSolutions and Valneva has turned up positive early-stage results, laying the groundwork for a potential technology transfer to Emergent.
mergent BioSolutions and Valneva’s Zika vaccine turns up positive early-phase data fiercepharma
December 04, 2018
A Zika vaccine candidate co-developed by Emergent BioSolutions and Valneva has turned up positive early-stage results, laying the groundwork for a potential technology transfer to Emergent.
Emergent and Valneva's Zika vaccine clears phase 1 fiercepharma
November 27, 2018
A Zika vaccine candidate co-developed by Emergent BioSolutions and Valneva has turned up positive early-stage results, laying the groundwork for a potential technology transfer to Emergent.
Emergent and Valneva's Zika vaccine clears phase 1 fiercepharma
November 26, 2018
A Zika vaccine candidate co-developed by Emergent BioSolutions and Valneva has turned up positive early-stage results, laying the groundwork for a potential technology transfer to Emergent.
Emergent and Valneva's Zika vaccine clears phase 1 fiercepharma
November 22, 2018
A Zika vaccine candidate co-developed by Emergent BioSolutions and Valneva has turned up positive early-stage results, laying the groundwork for a potential technology transfer to Emergent.
Tychan Completes Human Safety Studies for Monoclonal Antibody against Zika americanpharmaceuticalreview
October 30, 2018
Tychan has successfully completed Phase-1 safety trials for Tyzivumab, its first-in-class monoclonal antibody (mAb) therapeutic for Zika, in Singapore.
US scientists to develop rapid diagnostic test for Zika fiercepharma
July 02, 2018
The team has developed tiny platinum nanomotors that target Zika as well as microbeads that bind the virus.
CDI Labs Collaborates on Discovery of New Biomarkers for Zika Infection biospace
March 09, 2018
Newly published research in Molecular & Cellular Proteomics* describes a biomarker panel based on patient IgM antibodies that can differentiate between Zika and Dengue virus infection for a prolonged period after initial exposure.

Previous page 1 2 3 4 5 Next page